Camille Kotton
Clinical Director, Transplant and Immunocompromised Host Infectious Diseases, Infectious Diseases Division · University of Washington School of Medicine
Credentials: · · · · · ·
History
PresentTransplant and Immunocompromised Host Infectious Diseases · University of Washington School of Medicine
Research
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
Science · 1990 · 3,191 citations
Review · Transplantation · 2018 · First of 8 authors · 926 citations
A family of human cdc2-related protein kinases
The EMBO Journal · 1992 · 892 citations
18 papers
13 papers · 1 as a fellow
13 papers
11 papers
- MI
11 papers
10 papers
9 papers
- SH
9 papers
Grants
- 2005–2007
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $22.1K · Massachusetts General Hospital
- 2000–2005
Transcriptional Regulation of Tcpph in v.cholerae
National Institute of Allergy and Infectious Diseases · K08
Contact PI · $594.3K · Massachusetts General Hospital
Clinical trials
- 2025–2028
Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
Principal investigator · Recruiting · Phase 4
Camille N. Kotton, MD
- 2015–2016
Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients
Principal investigator · Terminated
QIAGEN Gaithersburg, Inc
- 2025–2028